NRG1 Type III (extracellular) Blocking Peptide (#BLP-NR113) is the original antigen used for immunization during Anti-NRG1 Type III (extracellular) Antibody (#ANR-113) generation. The blocking peptide binds and ‘blocks’ Anti-NRG1 Type III (extracellular) primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.